As CRISPR-Cas9 Technology Sets to Take Off, Uncertainty Swirls Around IP Landscape

The USPTO recently issued the Broad Institute the first patent for the CRISPR-Cas9 system, setting off a potential scramble for IP rights over a technology that is gaining wide adoption in the biotech space.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.
      Tony Fong is senior editor for GenomeWeb Daily News, tracking the firms that compete in the genomics tools and molecular diagnostics industries. E-mail Tony Fong or follow GWDN's headlines at @DailyNewsGW.

Related Stories